Dietary Citrate Reverses Vascular Aging and Reduces Atherosclerosis in Mice
New research shows citrate supplementation restores blood vessel function and extends lifespan by improving mitochondrial health.
Summary
Researchers found that adding citrate to drinking water significantly improved vascular health in aging mice. The study showed citrate restored elastic fiber integrity in blood vessels, improved endothelium-dependent relaxation, and reduced atherosclerotic plaques. Citrate also extended median lifespan, increased bone density, and improved physical performance. The benefits appear to work through activating AMPK pathways and improving mitochondrial function while reducing oxidative stress. This common food additive may offer a simple intervention for age-related cardiovascular diseases.
Detailed Summary
This groundbreaking study reveals that citrate, a common food additive and cellular energy source, can significantly reverse age-related vascular dysfunction and extend healthspan in mice. The research addresses a critical gap in longevity science by demonstrating how a simple dietary intervention can combat vascular aging, the primary driver of cardiovascular disease.
Researchers supplemented 18-month-old mice with 1% citrate in drinking water for 6 months and found remarkable improvements across multiple health parameters. Citrate extended both median and maximum lifespan while reducing frailty index scores. Vascular benefits included restored elastic fiber integrity (p<0.05), improved endothelium-dependent relaxation responses to acetylcholine, and reduced expression of aging marker p21. In atherosclerosis-prone ApoE knockout mice fed high-fat diets, citrate reduced atherosclerotic plaque size and necrotic core area.
Physical performance improvements were substantial: citrate increased bone mineral density, maximal grip strength, and balance speed in both aged and atherosclerotic mice. The intervention also elevated HDL cholesterol levels and reduced inflammatory markers like C-reactive protein. Mechanistic studies using human umbilical vein endothelial cells revealed citrate delayed cellular senescence by activating AMPK signaling pathways, improving mitochondrial respiration, ATP production, and reducing reactive oxygen species production.
The clinical implications are significant given citrate's safety profile as an FDA-approved food additive. The study suggests citrate supplementation could offer a practical intervention for age-related cardiovascular diseases, though human trials are needed to confirm these promising preclinical findings.
Key Findings
- Extended median and maximum lifespan in 18-month-old mice with 1% citrate supplementation
- Restored elastic fiber integrity in aged blood vessels (p<0.05 vs vehicle control)
- Improved endothelium-dependent vascular relaxation responses to acetylcholine
- Reduced atherosclerotic plaque size and necrotic core area in ApoE knockout mice
- Increased bone mineral density and maximal grip strength in both aged and atherosclerotic mice
- Elevated HDL cholesterol levels and reduced C-reactive protein inflammation marker
- Activated AMPK signaling and improved mitochondrial ATP production in endothelial cells
Methodology
The study used male C57BL/6 mice (18 months old) supplemented with 1% citrate in drinking water for 6 months, plus ApoE knockout mice on high-fat diets for 8 weeks. Sample sizes ranged from 6-14 mice per group. Vascular function was assessed via wire myography, histological analysis used EVG and immunofluorescence staining, and cellular mechanisms were studied in human umbilical vein endothelial cells. Statistical analysis employed student's t-tests and two-way ANOVA.
Study Limitations
The study was conducted only in male mice, limiting generalizability to females and humans. Long-term safety data for chronic citrate supplementation in humans is lacking. The optimal dosage for human application remains unclear, and the study did not examine potential interactions with medications or other supplements.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
